About Bleomycin hydrolase
Bleomycin hydrolase (BLMH) is a protein
from Homo sapiens identified by UniProt accession
Q13867, 455 residues long.
MolForge cross-references it against 0 known binders and
73 disease associations.
Target properties
| Protein name | Bleomycin hydrolase |
| UniProt accession | Q13867 |
| Gene | BLMH |
| Organism | Homo sapiens |
| Length | 455 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (73)
Diseases linked to this target (Open Targets).
- alkaline phosphatase measurement · score 0.29
- total cholesterol measurement · score 0.28
- blood protein measurement · score 0.28
- sex hormone-binding globulin measurement · score 0.27
- clear cell renal carcinoma · score 0.18
- smoking status measurement · score 0.08
- intelligence · score 0.05
- body height · score 0.05
- breast milk measurement · score 0.04
- myxedema · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13867-F1 | alphafold | PREDICTED | 98.01 | — |
Amino-acid sequence (455 residues)
MSSSGLNSEK VAALIQKLNS DPQFVLAQNV GTTHDLLDIC LKRATVQRAQ HVFQHAVPQE GKPITNQKSS GRCWIFSCLN VMRLPFMKKL NIEEFEFSQS YLFFWDKVER CYFFLSAFVD TAQRKEPEDG RLVQFLLMNP ANDGGQWDML VNIVEKYGVI PKKCFPESYT TEATRRMNDI LNHKMREFCI RLRNLVHSGA TKGEISATQD VMMEEIFRVV CICLGNPPET FTWEYRDKDK NYQKIGPITP LEFYREHVKP LFNMEDKICL VNDPRPQHKY NKLYTVEYLS NMVGGRKTLY NNQPIDFLKK MVAASIKDGE AVWFGCDVGK HFNSKLGLSD MNLYDHELVF GVSLKNMNKA ERLTFGESLM THAMTFTAVS EKDDQDGAFT KWRVENSWGE DHGHKGYLCM TDEWFSEYVY EVVVDRKHVP EEVLAVLEQE PIILPAWDPM GALAE
Explore Bleomycin hydrolase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets